Manlong Xu

628 total citations
17 papers, 325 citations indexed

About

Manlong Xu is a scholar working on Rheumatology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Manlong Xu has authored 17 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Molecular Biology and 5 papers in Ophthalmology. Recurrent topics in Manlong Xu's work include Spondyloarthritis Studies and Treatments (7 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Manlong Xu is often cited by papers focused on Spondyloarthritis Studies and Treatments (7 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Manlong Xu collaborates with scholars based in China, Canada and United Kingdom. Manlong Xu's co-authors include J. G. Sivak, David J. McCanna, Ian M. MacDonald, Zetao Liao, Jieruo Gu, Qiujing Wei, Shuangyan Cao, Qiuxia Li, Ou Jin and Jianlin Huang and has published in prestigious journals such as PLoS ONE, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Manlong Xu

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manlong Xu China 7 97 96 58 44 42 17 325
Ying Zou China 15 66 0.7× 108 1.1× 88 1.5× 28 0.6× 19 0.5× 62 618
Ronglan Zhao China 15 70 0.7× 246 2.6× 120 2.1× 59 1.3× 16 0.4× 48 537
Anwar Fathollahi Iran 11 67 0.7× 189 2.0× 83 1.4× 49 1.1× 6 0.1× 20 440
Katsuyuki Horie Japan 13 56 0.6× 206 2.1× 17 0.3× 19 0.4× 10 0.2× 20 545
Aijun Zuo China 16 46 0.5× 143 1.5× 278 4.8× 29 0.7× 55 1.3× 32 575
P Santoianni Italy 10 38 0.4× 122 1.3× 29 0.5× 34 0.8× 22 0.5× 23 443
Claudia Skazik Germany 14 25 0.3× 108 1.1× 127 2.2× 88 2.0× 10 0.2× 32 633
Abdul Qadir Pakistan 9 15 0.2× 260 2.7× 37 0.6× 53 1.2× 18 0.4× 34 455
Viranga Tilakaratna United Kingdom 11 17 0.2× 254 2.6× 162 2.8× 40 0.9× 138 3.3× 14 558

Countries citing papers authored by Manlong Xu

Since Specialization
Citations

This map shows the geographic impact of Manlong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlong Xu more than expected).

Fields of papers citing papers by Manlong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manlong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlong Xu. The network helps show where Manlong Xu may publish in the future.

Co-authorship network of co-authors of Manlong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Manlong Xu. A scholar is included among the top collaborators of Manlong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manlong Xu. Manlong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Hui, Manlong Xu, Ying‐Jian Sun, Shengqing Yu, & Deqin Yang. (2024). [Inhibitory effect of Streptococcus mutans antisense vicK RNA regulating the cariogenicity of oral streptococci multi-species biofilm].. PubMed. 59(1). 64–70. 1 indexed citations
2.
Xu, Manlong, Ioannis Dimopoulos, Paul Crichton, et al.. (2022). AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy. American Journal of Ophthalmology. 248. 145–156. 6 indexed citations
3.
Doucette, Lance P., et al.. (2021). Whole exome sequencing reveals putatively novel associations in retinopathies and drusen formation. European Journal of Human Genetics. 29(8). 1171–1185. 2 indexed citations
4.
Xu, Manlong, J. G. Sivak, & David J. McCanna. (2021). Neutralization of the eye and skin irritant benzalkonium chloride using UVC radiation. Cutaneous and Ocular Toxicology. 40(2). 78–84. 1 indexed citations
5.
Xu, Manlong, et al.. (2020). Visual Field Progression in Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 61(6). 56–56. 29 indexed citations
6.
Xu, Manlong, J. G. Sivak, & David J. McCanna. (2020). Ocular toxicology: synergism of UV radiation and benzalkonium chloride. Cutaneous and Ocular Toxicology. 39(4). 370–379. 4 indexed citations
7.
Xu, Manlong, Ioannis Dimopoulos, David G. Birch, et al.. (2020). Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Translational Vision Science & Technology. 9(7). 21–21. 5 indexed citations
8.
Xu, Manlong, et al.. (2018). [Analysis on the trend of innovation and development in the field of ophthalmology].. PubMed. 54(6). 452–463. 3 indexed citations
9.
Zhang, Yanli, Zetao Liao, Qiujing Wei, et al.. (2016). A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait. PLoS ONE. 11(12). e0166888–e0166888. 2 indexed citations
10.
Lin, Zhiming, Zetao Liao, Jianlin Huang, et al.. (2015). Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis Patients. BioMed Research International. 2015. 1–7. 3 indexed citations
11.
Xu, Manlong, David J. McCanna, & J. G. Sivak. (2014). Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells. Journal of Pharmacological and Toxicological Methods. 71. 1–7. 142 indexed citations
12.
Lin, Zhiming, Zetao Liao, Jianlin Huang, et al.. (2014). Evaluation of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis in Chinese patients with chronic back pain: results of a 2‐year follow‐up study. International Journal of Rheumatic Diseases. 17(7). 782–789. 12 indexed citations
13.
Hu, Zaiying, Manlong Xu, Zetao Liao, et al.. (2014). Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitis.. PubMed. 32(1). 22–7. 4 indexed citations
14.
Xu, Manlong, J. G. Sivak, & David J. McCanna. (2013). Comparison of the Effects of Ophthalmic Solutions on Human Corneal Epithelial Cells Using Fluorescent Dyes. Journal of Ocular Pharmacology and Therapeutics. 29(9). 794–802. 24 indexed citations
15.
Hu, Zaiying, Manlong Xu, Qiuxia Li, et al.. (2012). Adalimumab significantly reduces inflammation and serum DKK‐1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis. International Journal of Rheumatic Diseases. 15(4). 358–365. 42 indexed citations
16.
Li, Chao, Jinxian Huang, Qiujing Wei, et al.. (2010). ERAP1Is Associated with Ankylosing Spondylitis in Han Chinese. The Journal of Rheumatology. 38(2). 317–321. 28 indexed citations
17.
Gu, Jieruo, Peigen He, Jiesheng Gao, et al.. (2009). Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatology International. 31(2). 233–238. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Zou Breakdown of academic impact, for papers by Ronglan Zhao Breakdown of academic impact, for papers by Anwar Fathollahi Breakdown of academic impact, for papers by Katsuyuki Horie Breakdown of academic impact, for papers by Aijun Zuo Breakdown of academic impact, for papers by P Santoianni Breakdown of academic impact, for papers by Claudia Skazik Breakdown of academic impact, for papers by Abdul Qadir Breakdown of academic impact, for papers by Viranga Tilakaratna
Rankless by CCL
2026